Urothelial carcinoma is also called transitional cell carcinoma because the cells in the urothelium can transition between different shapes to enable the bladder to stretch and shrink as needed.

The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma. The United States Food ... function through the activation of T cells and ...

Actuate Therapeutics, Inc. announced that data on their investigational drug elraglusib, designed to treat advanced salivary gland carcinoma by ... and enhancing immune cell function in cancer ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

"Elraglusib with chemotherapy and immune priming represents a novel sequential therapy approach to treat advanced salivary cancers. We were encouraged by the response rate among the non-Adenoid Cystic ...

A white or red patch on your tongue, gums, tonsils, or lining of your mouth may be a possible symptom of squamous cell carcinoma. How oral cancer looks and feels varies considerably. The skin may ...

Molecular alteration patterns were a better predictor of aggressive tumor behavior than tumor size in papillary thyroid carcinoma.

Papillary renal cell ... salivary gland tumors) The names may seem more complicated but it also means they're more precise, and that allows healthcare providers to be more precise in their evaluation ...

This paper investigates how isoform II of transcription factor RUNX2 promotes cell survival and proliferation in oral squamous cell carcinoma cell lines. The authors used gain and loss of function ...

There have been only 24 documented occurrences of the extremely uncommon giant cell tumour of the parotid gland. We report an additional case of a female patient in her late 40s who presented with a 2 ...